- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 127,860 | 01.07.24 20:35:48 | +4,060 | +3,28% | 127,850 | 127,870 | 129,540 | 123,800 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 85,125 | 01.07.24 20:32:23 | +0,865 | +1,03% | 85,060 | 85,410 | 83,760 | 84,260 |
